Eva Villaron
Overview
Explore the profile of Eva Villaron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-Santos M, Garcia-Arranz M, Andreu E, Garcia-Hernandez A, Lopez-Parra M, Villaron E, et al.
Front Immunol
. 2022 Jul;
13:918565.
PMID: 35812460
MSCs products as well as their derived extracellular vesicles, are currently being explored as advanced biologics in cell-based therapies with high expectations for their clinical use in the next few...
2.
Campo A, Gonzalez-Ruiz J, Andreu E, Alcaide A, Ocon M, De-Torres J, et al.
ERJ Open Res
. 2021 Jul;
7(2).
PMID: 34195252
Rationale: Idiopathic pulmonary fibrosis (IPF) has a dismal prognosis. Mesenchymal stromal cells (MSCs) have shown benefit in other inflammatory diseases. Objectives: To evaluate the safety and feasibility of endobronchial administration...
3.
Sanchez-Guijo F, Caballero-Velazquez T, Lopez-Villar O, Redondo A, Parody R, Martinez C, et al.
Biol Blood Marrow Transplant
. 2014 Jun;
20(10):1580-5.
PMID: 24952358
We evaluated the feasibility, safety, and efficacy of the administration of 4 sequential doses (intravenously administered on days 1, 4, 11, and 18) of cryopreserved bone marrow-derived mesenchymal stromal cells...
4.
Carrancio S, Lopez-Holgado N, Sanchez-Guijo F, Villaron E, Barbado V, Tabera S, et al.
Exp Hematol
. 2008 May;
36(8):1014-21.
PMID: 18468767
Objective: Optimization of the mesenchymal stem cells (MSC) isolation and expansion method. Materials And Methods: Mononuclear cells (MNC) from bone marrow aspirates were obtained by both density gradient centrifugation (standard...
5.
Blanco B, Perez-Simon J, Sanchez-Abarca L, Carvajal-Vergara X, Mateos J, Vidriales B, et al.
Blood
. 2005 Nov;
107(9):3575-83.
PMID: 16282346
We explored the ability of the proteasome inhibitor bortezomib, which prevents nuclear factor kappaB (NF-kappaB) activation, to block T-cell activation, proliferation, and survival within alloreactive compared with resting T cells....
6.
Sanchez-Guijo F, Sanchez-Abarca L, Villaron E, Lopez-Holgado N, Alberca M, Vazquez L, et al.
Exp Hematol
. 2005 Jul;
33(8):935-43.
PMID: 16038787
We tested the principle of whether patient long-term hematopoiesis following allogeneic stem cell transplantation (allo-SCT) reflects the characteristics of the hematopoiesis of their respective donor. For this purpose, we analyzed...
7.
Sanchez-Guijo F, Sanchez-Abarca L, Bueno C, Villaron E, Lopez-Holgado N, Vazquez L, et al.
Biol Blood Marrow Transplant
. 2005 Apr;
11(5):354-61.
PMID: 15846289
We have addressed whether patients' immune system status after allogeneic stem cell transplantation, assessed more than 1 year after the procedure, recovers normal function as compared with that of their...
8.
Lopez-Holgado N, Pata C, Villaron E, Sanchez-Guijo F, Alberca M, Martin A, et al.
Haematologica
. 2005 Mar;
90(3):353-9.
PMID: 15749668
Background And Objectives: There is wide interindividual variation in progenitor cell mobilization. The present study was aimed to analyze steady state hematopoiesis in healthy donors and its influence on hematopoietic...
9.
Lopez-Holgado N, Arroyo J, Pata C, Villaron E, Sanchez Guijo F, Martin A, et al.
Leuk Res
. 2004 Sep;
28(11):1181-7.
PMID: 15380343
The present work analyzes the hematopoietic progenitor cells (HPC) in myelodysplastic syndrome (MDS) patients using both an immunophenotypical and a functional approaches in order to know whether they are similar...
10.
Del Canizo M, Fernandez M, Lopez A, Vidriales B, Villaron E, Arroyo J, et al.
Haematologica
. 2003 Apr;
88(4):402-7.
PMID: 12681967
Background And Objectives: In contrast with hematologic malignancies in which the value of immunophenotypic studies is well established, information on the immunophenotypic characteristics of myelodysplastic syndromes (MDS) is scanty. The...